Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28541-108399

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.8)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Convertible Promissory Notes and Other Notes Payable (Details Narrative) - USD ($)									1 Months Ended					3 Months Ended		7 Months Ended	10 Months Ended	12 Months Ended
	Mar. 25, 2016	Dec. 11, 2015	Nov. 23, 2015	Nov. 11, 2015	Sep. 02, 2015	Aug. 15, 2015	Jun. 26, 2015	May 05, 2015	Dec. 31, 2015	Nov. 30, 2015	May 14, 2015	Jan. 31, 2015	Apr. 30, 2014	Sep. 30, 2015	Jun. 30, 2015	Sep. 30, 2015	Mar. 31, 2016	Mar. 31, 2016	Mar. 31, 2015	Jun. 13, 2015	May 12, 2015	Mar. 31, 2014
Aggregate face amount																			$ 1,302,600
Extinguishment of debt, amount																$ 17,200,000
Non- cash loss on extinguishment of debt																$ 26,700,200
Share price (in dollars per share)																	$ 8.75	$ 8.75
Warrant [Member]
Number of shares issued	230,000	37,500	7,500	1,123,533	650,000					15,750		381,000
Warrant exercisable date				Mar. 19, 2019
Warrant exercise price (in dollars per share)					$ 9.25
Share price (in dollars per share)	$ 8.00	$ 5.00	$ 6.75	$ 6.50	$ 9.11							$ 8.00
Warrant fair value				$ 492,600	$ 3,692,900							$ 1,756,900
Series B Preferred Stock [Member]
Dividend rate																		10.00%
Private Placement [Member] \| Series B Preferred Stock [Member]
Number of shares issued																	717,978
Securities Purchase Agreements [Member] \| Private Placement [Member] \| Warrant [Member]
Number of shares issued																		833,020
Warrant fair value																	$ 5,168,400	$ 5,168,400
Icahn School of Medicine at Mount Sinai [Member]
Stem cell technology license maintenance fees and reimbursable patent prosecution costs													$ 288,400
Additional Stem cell technology license maintenance fees and reimbursable patent prosecution costs													$ 35,800
Share price (in dollars per share)													$ 9.40
Icahn School of Medicine at Mount Sinai [Member] \| Restricted Common Stock [Member]
Number of shares issued													15,000
Icahn School of Medicine at Mount Sinai [Member] \| Warrant [Member]
Number of shares issued													15,000
Warrant exercisable date													Mar. 31, 2019
Warrant exercise price (in dollars per share)													$ 10.00
Share price (in dollars per share)													$ 9.40
Warrant fair value													$ 89,200
Accredited Investors [Member] \| Private Placement [Member]
Aggregate face amount																			3,113,500			$ 3,113,500
Platinum Long Term Growth VII, LLC [Member] \| Warrant [Member]
Warrant exercise price (in dollars per share)																					$ 7.00
Platinum Long Term Growth VII, LLC [Member] \| Series B Preferred Stock [Member]
Number of shares issued						458,571			235,714
Share price (in dollars per share)																					$ 10.00
Platinum Long Term Growth VII, LLC [Member] \| Private Placement [Member] \| Warrant [Member]
Number of shares issued																		717,976
Platinum Long Term Growth VII, LLC [Member] \| Private Placement [Member] \| Series B Preferred Stock [Member]
Number of shares issued																		717,976
Platinum Long Term Growth VII, LLC [Member] \| Securities Purchase Agreements [Member] \| Private Placement [Member] \| Series B Preferred Stock [Member]
Number of shares issued								142,857
10% Promissory Note [Member] \| Icahn School of Medicine at Mount Sinai [Member]
Aggregate face amount													$ 300,000
Repayment of debt																			100,000
Non- cash loss on extinguishment of debt														$ 16,900	$ 386,200
Debt conversion amount							$ 270,400
10% Promissory Note [Member] \| Icahn School of Medicine at Mount Sinai [Member] \| Restricted Common Stock [Member]
Number of shares issued													15,000
10% Promissory Note [Member] \| Icahn School of Medicine at Mount Sinai [Member] \| Warrant [Member]
Number of shares issued													15,000
Warrant exercisable date													Mar. 31, 2019
Warrant exercise price (in dollars per share)							$ 7.00
10% Promissory Note [Member] \| Icahn School of Medicine at Mount Sinai [Member] \| Series B Preferred Stock [Member]
Share price (in dollars per share)							$ 16.00													$ 12.00
10% Convertible Promissory Note (2014 Unit Notes) [Member]
Aggregate face amount																			$ 4,066,900
Maturity date																			Mar. 31, 2015
10% Convertible Promissory Note (2014 Unit Notes) [Member] \| Securities Purchase Agreements [Member] \| Private Placement [Member]
Description of conversion terms																		Entitling the 2014 Unit Note holders at the time of conversion to the 25% Qualified Financing conversion premium under the terms of the 2014 Unit Notes.
Debt conversion amount																		$ 4,664,800
10% Convertible Promissory Note (2014 Unit Notes) [Member] \| Securities Purchase Agreements [Member] \| Private Placement [Member] \| Series B Preferred Stock [Member]
Number of shares issued																		833,020
10% Convertible Promissory Note (2014 Unit Notes) [Member] \| Accredited Investors [Member]
Debt conversion amount								$ 1,500,000
10% Convertible Promissory Note (2014 Unit Notes) [Member] \| Accredited Investors [Member] \| Securities Purchase Agreements [Member]
Aggregate face amount											$ 280,000
Debt instrument maturity date range start											Apr. 30, 2015
Debt instrument maturity date range end											May 15, 2015
10% Convertible Promissory Note (2014 Unit Notes) [Member] \| Accredited Investors [Member] \| Securities Purchase Agreements [Member] \| Private Placement [Member]
Aggregate face amount											$ 280,000
Debt instrument maturity date range start											Apr. 30, 2015
Debt instrument maturity date range end											May 15, 2015
Debt conversion price (in dollars per share)											$ 10.00
Description of conversion terms											(i) an equity or equity-based public financing registered with the SEC, or (ii) an equity or equity-based private placement, or series of private placements, not registered with the SEC, in either case resulting in gross cash proceeds to us of at least $10.0 million prior to Maturity (a Qualified Financing), the Outstanding Balance of the 2014 Unit Notes would automatically convert into securities substantially similar to those sold in the Qualified Financing, based on the following formula: (the Outstanding Balance as of the closing of the Qualified Financing) x 1.25 / (the per security price of the securities sold in the Qualified Financing).
Amortized discounts											$ 277,200
Percentage of excess effective interest rates											10000.00%
10% Convertible Promissory Note (2014 Unit Notes) [Member] \| Platinum Long Term Growth VII, LLC [Member] \| Private Placement [Member]
Aggregate face amount																			$ 1,250,000
10% Convertible Promissory Note (2014 Unit Notes) [Member] \| Platinum Long Term Growth VII, LLC [Member] \| Securities Purchase Agreements [Member]
Debt conversion price (in dollars per share)																			$ 10.00
10% Convertible Promissory Note (2014 Unit Notes) [Member] \| Platinum Long Term Growth VII, LLC [Member] \| Securities Purchase Agreements [Member] \| Private Placement [Member]
Non- cash loss on extinguishment of debt															$ 5,942,700			$ 2,237,100
Debt conversion amount																		$ 1,345,700
Maturity date																		Mar. 31, 2015
Debt conversion premium																		$ 1,166,200
Debt fair value																	$ 7,676,200	$ 7,676,200
10% Convertible Promissory Note (2014 Unit Notes) [Member] \| Platinum Long Term Growth VII, LLC [Member] \| Securities Purchase Agreements [Member] \| Private Placement [Member] \| Series B Preferred Stock [Member]
Share price (in dollars per share)																	$ 10.00	$ 10.00
Acquired Unit Notes [Member] \| Platinum Long Term Growth VII, LLC [Member]
Debt conversion amount																		$ 1,487,900
Acquired Unit Notes [Member] \| Platinum Long Term Growth VII, LLC [Member] \| Series B Preferred Stock [Member]
Share price (in dollars per share)																	10.00	$ 10.00
Investor Unit Notes [Member] \| Warrant [Member]
Number of shares issued																		327,016
Share price (in dollars per share)																	8.00	$ 8.00
Investor Unit Notes [Member] \| Platinum Long Term Growth VII, LLC [Member]
Debt conversion amount																		$ 1,831,200
Investor Unit Notes [Member] \| Platinum Long Term Growth VII, LLC [Member] \| Series B Preferred Stock [Member]
Share price (in dollars per share)																	$ 8.00	$ 8.00